Skip to main content
Erschienen in: Diseases of the Colon & Rectum 12/2004

01.12.2004 | Original Contributions

Distilled Water Peritoneal Lavage After Colorectal Cancer Surgery

verfasst von: Emmanuel L. Huguet, B.Sc., M.B., Ch.B., F.R.C.S., Ph.D., Neil J. Keeling, M.B.B.S., M.S., F.R.C.S.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 12/2004

Einloggen, um Zugang zu erhalten

PURPOSE

Tumor cells exfoliated into the peritoneal cavity during colorectal cancer surgery are viable and tumorigenic and may contribute to peritoneal recurrence. Although commonly used, the tumoricidal effectiveness of antiseptics in peritoneal lavage is doubted because of their chemical alteration by peritoneal secretions. In contrast, osmotic lysis by incubation in distilled water may offer an effective tumoricidal activity. Data defining the susceptibility of colorectal carcinoma cells to osmotic lysis are lacking and hence there is no consensus on optimal lavage methodology.

METHODS

We examined the cytocidal activity of water on colorectal cancer cell lines in culture and determined the effect of peritoneal secretions in vivo on the tumoricidal effectiveness of water.

RESULTS

Incubation of cells in distilled water resulted in cell lysis, with 100 percent lysis achieved after 14 minutes of incubation. In vivo, contamination of lavage water by peritoneal secretions produced a resultant solution with an osmolality of 50 mM. Sequential lavages reduced this contamination, enabling a final resultant solution with an osmolality of 10 mM, which produced 100 percent cell lysis after 32 minutes of incubation.

CONCLUSIONS

Current peritoneal lavage methodology is inadequate because complete cell lysis requires water incubation for longer time periods than is currently practiced. Solutions to this problem are discussed.
Literatur
1.
Zurück zum Zitat Leather, AJ, Kocjan, G, Savage, F, et al. 1994Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancerDis Colon Rectum378149PubMed Leather, AJ, Kocjan, G, Savage, F,  et al. 1994Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancerDis Colon Rectum378149PubMed
2.
Zurück zum Zitat Wong, LS, Morris, AG, Fraser, IA 1996The exfoliation of free malignant cells in the peritoneal cavity during resection of colorectal cancerSurg Oncol511521PubMedCrossRef Wong, LS, Morris, AG, Fraser, IA 1996The exfoliation of free malignant cells in the peritoneal cavity during resection of colorectal cancerSurg Oncol511521PubMedCrossRef
3.
Zurück zum Zitat Wind, P, Norklinger, B, Roger, V, Kahlil, A, Guin, E, Parc, R 1999Long-term prognostic value of positive peritoneal washing in colon cancerScand J Gastroenterol3460610CrossRefPubMed Wind, P, Norklinger, B, Roger, V, Kahlil, A, Guin, E, Parc, R 1999Long-term prognostic value of positive peritoneal washing in colon cancerScand J Gastroenterol3460610CrossRefPubMed
4.
Zurück zum Zitat Skipper, D, Cooper, AJ, Marston, JE, Taylor, I 1987Exfoliated cells and in vitro growth in colorectal cancerBr J Surg74104952PubMed Skipper, D, Cooper, AJ, Marston, JE, Taylor, I 1987Exfoliated cells and in vitro growth in colorectal cancerBr J Surg74104952PubMed
5.
Zurück zum Zitat Fermor, B, Umpleby, HC, Lever, JV, Symes, MO, Williamson, RC 1986Proliferative and metastatic potential of exfoliated colorectal cancer cellsJ Natl Cancer Inst763479PubMed Fermor, B, Umpleby, HC, Lever, JV, Symes, MO, Williamson, RC 1986Proliferative and metastatic potential of exfoliated colorectal cancer cellsJ Natl Cancer Inst763479PubMed
6.
Zurück zum Zitat Symes, MO, Fermor, B, Umpleby, HC, Tribe, CR, Williamson, RC 1984Cells exfoliated from colorectal cancers can proliferate in immune deprived miceBr J Cancer504235PubMed Symes, MO, Fermor, B, Umpleby, HC, Tribe, CR, Williamson, RC 1984Cells exfoliated from colorectal cancers can proliferate in immune deprived miceBr J Cancer504235PubMed
7.
Zurück zum Zitat Hase, K, Ueno, H, Kuranaga, N, Utsunomiya, K, Kanabe, S, Mochizuki, H 1998Intraperitoneal exfoliated cancer cells in patients with colorectal cancerDis Colon Rectum41113440PubMed Hase, K, Ueno, H, Kuranaga, N, Utsunomiya, K, Kanabe, S, Mochizuki, H 1998Intraperitoneal exfoliated cancer cells in patients with colorectal cancerDis Colon Rectum41113440PubMed
8.
Zurück zum Zitat Shepherd, NA, Baxter, KJ, Love, SB 1997The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluationGastroenterology1121096102PubMed Shepherd, NA, Baxter, KJ, Love, SB 1997The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluationGastroenterology1121096102PubMed
9.
Zurück zum Zitat Schott, A, Vogel, I, Krueger, U, et al. 1998Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic markerAnn Surg2273729CrossRefPubMed Schott, A, Vogel, I, Krueger, U,  et al. 1998Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic markerAnn Surg2273729CrossRefPubMed
10.
Zurück zum Zitat MacFarlane, JK, Ryall, RD, Heald, RJ 1993Mesorectal excision for rectal cancerLancet34145760CrossRefPubMed MacFarlane, JK, Ryall, RD, Heald, RJ 1993Mesorectal excision for rectal cancerLancet34145760CrossRefPubMed
11.
Zurück zum Zitat Adam, R, Avisar, E, Ariche, A, et al. 2001Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectalAnn Surg Oncol834753CrossRefPubMed Adam, R, Avisar, E, Ariche, A,  et al. 2001Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectalAnn Surg Oncol834753CrossRefPubMed
12.
Zurück zum Zitat Elias, D, Blot, F, Otmany, A, et al. 2001Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapyCancer92716CrossRefPubMed Elias, D, Blot, F, Otmany, A,  et al. 2001Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapyCancer92716CrossRefPubMed
13.
Zurück zum Zitat Umpleby, HC, Williamson, RC 1984The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinomaAnn R Coll Surg Engl661924PubMed Umpleby, HC, Williamson, RC 1984The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinomaAnn R Coll Surg Engl661924PubMed
14.
Zurück zum Zitat Docherty, JG, McGregor, JR, Purdie, CA, Galloway, DJ, O’Dwyer, PJ 1995Efficacy of tumoricidal agents in vitro and in vivoBr J Surg8210502PubMed Docherty, JG, McGregor, JR, Purdie, CA, Galloway, DJ, O’Dwyer, PJ 1995Efficacy of tumoricidal agents in vitro and in vivoBr J Surg8210502PubMed
15.
Zurück zum Zitat Basha, G, Penninckx, F, Yap, P 1998Influence of blood components and faeces on the in vitro cancericidal activity of povidone-iodineBr J Surg855347CrossRefPubMed Basha, G, Penninckx, F, Yap, P 1998Influence of blood components and faeces on the in vitro cancericidal activity of povidone-iodineBr J Surg855347CrossRefPubMed
16.
Zurück zum Zitat Basha, G, Ghirardi, M, Geboes, K, Yap, SH, Penninckx, F 2000Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding: experimental study in ratsDis Colon Rectum4317138PubMed Basha, G, Ghirardi, M, Geboes, K, Yap, SH, Penninckx, F 2000Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding: experimental study in ratsDis Colon Rectum4317138PubMed
17.
Zurück zum Zitat Iwahashi, T, Okochi, E, Ono, K, Sugawara, I, Tsuruo, T, Mori, S 1991Establishment of multidrug resistant human colorectal carcinoma HCT-15 cell lines and their propertiesAnticancer Res11130912PubMed Iwahashi, T, Okochi, E, Ono, K, Sugawara, I, Tsuruo, T, Mori, S 1991Establishment of multidrug resistant human colorectal carcinoma HCT-15 cell lines and their propertiesAnticancer Res11130912PubMed
18.
Zurück zum Zitat Trainer, DL, Kline, T, McCabe, FL, et al. 1988Biological characterization and oncogene expression in human colorectal carcinoma cell linesInt J Cancer4128796PubMed Trainer, DL, Kline, T, McCabe, FL,  et al. 1988Biological characterization and oncogene expression in human colorectal carcinoma cell linesInt J Cancer4128796PubMed
Metadaten
Titel
Distilled Water Peritoneal Lavage After Colorectal Cancer Surgery
verfasst von
Emmanuel L. Huguet, B.Sc., M.B., Ch.B., F.R.C.S., Ph.D.
Neil J. Keeling, M.B.B.S., M.S., F.R.C.S.
Publikationsdatum
01.12.2004
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 12/2004
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-004-0788-4

Weitere Artikel der Ausgabe 12/2004

Diseases of the Colon & Rectum 12/2004 Zur Ausgabe

Letters to the Editor

The Authors Reply

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.